NASDAQ:AGIO - US00847X1046 - Common Stock
Overall AGIO gets a fundamental rating of 5 out of 10. We evaluated AGIO against 547 industry peers in the Biotechnology industry. While AGIO has a great health rating, there are worries on its profitability. While showing a medium growth rate, AGIO is valued expensive at the moment.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 44.19% | ||
ROE | 47.47% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | 1590.42% | ||
GM | 88.18% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | 12.62 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 14.48 | ||
Quick Ratio | 14.04 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
39.27
+0.81 (+2.11%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 55.82 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 1.67 | ||
P/tB | 1.67 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 44.19% | ||
ROE | 47.47% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | 1590.42% | ||
GM | 88.18% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 57.67% | ||
Cap/Sales | 7.41% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 14.48 | ||
Quick Ratio | 14.04 | ||
Altman-Z | 12.62 |